BYD Achieved Record It's About Going Offensive
BYD again proves it can set records, this time overseas. The question for investors is how long that momentum lasts a...
Value Comparisons For Travel Points Redemptions
Explore value comparisons for travel points redemptions to make informed choices. Get the most out of your rewards.
22,567 articles
AT&T Verizon: Which Cell Stock Is a Better Buy in 2026?
As 5G and fiber roll out, investors must weigh income vs. growth. This guide compares AT&T and Verizon on dividends, ...
SpaceX Just Fell Below: What Investors Should Do Next
SpaceX just fell below its IPO price, a moment that sparks questions for every investor. This guide breaks down what ...
Pfizer Stock Underrated Healthcare Play for 2025 Today
Is Pfizer stock undervalued in the crowded healthcare space? This deep dive weighs cash flow, dividends, pipeline pot...
Intuit (INTU) 2026 Earnings: Investor Guide
This fresh analysis explores intuit (intu) 2026 earnings, highlighting key growth drivers, profitability advances, an...
MediWound (MDWD) 2025 Earnings: A Comprehensive Look
As 2025 unfolds, MediWound faces a pivotal year for debt, cash, and milestones. This analysis breaks down what mediwo...
Walmart Metric Watch 2026: Key Indicators for Investors
In 2026, investors are focusing on profits, not just sales. This guide explains the walmart metric watch 2026 framewo...
Latest Super Micro Computer: A Buying Opportunity or Risk?
A volatile market mood meets a high-stakes regulatory backdrop. This guide unpacks how to evaluate the latest super m...
Percent Owners Sell Million: Inside V2X Insider Moves
Five insiders each owning at least 10% recently sold shares of V2X, Inc., totaling 2.55 million shares for about $173...
This Million Shows Growing Confidence in 10x Genomics
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Securities Slashes XOVR Stake: GTS Sells $354 Million
GTS Securities recently sold a large chunk of its XOVR exposure, shedding about 19.46 million shares worth roughly 35...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status